PMID- 32339349 OWN - NLM STAT- MEDLINE DCOM- 20210329 LR - 20210329 IS - 1095-8355 (Electronic) IS - 1065-6995 (Linking) VI - 44 IP - 8 DP - 2020 Aug TI - A comparative study of hBM-MSCs' differentiation toward osteogenic lineage in the presence of progesterone and estrogen hormones separately and concurrently in vitro. PG - 1701-1713 LID - 10.1002/cbin.11364 [doi] AB - Promising cell sources for tissue engineering comprise bone marrow derived-mesenchymal stem cells (BM-MSCs) that have multiple differentiation potentials. Also, sex hormones act as important elements in bone development and maintenance, and the roles of two female sex steroid hormones known as estrogen (17-beta estradiol) and progesterone in osteogenic differentiation of human BM-MSCs (hBM-MSCs) are studied. For this purpose, hBM-MSCs were treated with a 1 x 10(-6) M concentration of 17-beta estradiol and progesterone separately and simultaneously while the optimum concentrations were obtained by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Osteogenic differentiation tests including measurement of alkaline phosphatase (ALP) enzyme activity, the content of total mineral calcium, mineralized matrix staining by Alizarin Red and Von Kossa solutions, real-time reverse transcription polymerase chain reaction (RT-PCR), and immunofluorescence staining were carried out on Days 7 and 14 of differentiation. To exhibit the morphology of the cells, the BM-MSCs were stained with acridine orange (AO) solution. In this study, the results of ALP activity assay, calcium content and real-time RT-PCR assay and also all tests of differentiation staining have shown that 17-beta estradiol has been recognized as an enhancing factor of osteogenic differentiation. Furthermore, MTT assay and AO staining revealed progesterone as a factor that seriously improved the proliferation of hBM-MSCs. Generally, the 17-beta estradiol individually or in the presence of progesterone has more effects on BM-MSCs' osteogenic differentiation compared to progesterone alone. In this study, it is indicated that the effect of the 17-beta estradiol and progesterone concurrently was the same as individual 17-beta estradiol on the differentiation of hBM-MSCs. CI - (c) 2020 International Federation for Cell Biology. FAU - Soltanyzadeh, Maryam AU - Soltanyzadeh M AD - Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. FAU - Ghollasi, Marzieh AU - Ghollasi M AD - Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. FAU - Halabian, Raheleh AU - Halabian R AUID- ORCID: 0000-0002-3363-8276 AD - Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. FAU - Shams, Mehdi AU - Shams M AD - Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran. LA - eng PT - Comparative Study PT - Journal Article DEP - 20200506 PL - England TA - Cell Biol Int JT - Cell biology international JID - 9307129 RN - 4G7DS2Q64Y (Progesterone) RN - 4TI98Z838E (Estradiol) SB - IM MH - Bone Marrow Cells/cytology MH - Cell Lineage MH - Cell Proliferation/drug effects MH - Cells, Cultured MH - Estradiol/*pharmacology MH - Female MH - Humans MH - Mesenchymal Stem Cells/*cytology/drug effects MH - Osteogenesis/*drug effects MH - Progesterone/*pharmacology OTO - NOTNLM OT - estrogen OT - mesenchymal stem cells OT - osteogenic differentiation OT - progesterone EDAT- 2020/04/28 06:00 MHDA- 2021/03/30 06:00 CRDT- 2020/04/28 06:00 PHST- 2019/12/18 00:00 [received] PHST- 2020/04/12 00:00 [revised] PHST- 2020/04/25 00:00 [accepted] PHST- 2020/04/28 06:00 [pubmed] PHST- 2021/03/30 06:00 [medline] PHST- 2020/04/28 06:00 [entrez] AID - 10.1002/cbin.11364 [doi] PST - ppublish SO - Cell Biol Int. 2020 Aug;44(8):1701-1713. doi: 10.1002/cbin.11364. Epub 2020 May 6.